Human Genome Sciences (HGS), a medical science firm, has named David Southwell as executive vice president (EVP) and chief financial officer (CFO). He will report directly to Thomas Watkins, president and chief executive officer (CEO), and will serve as a member of the management committee. Southwell has served as a member of the HGS board of directors since July 2008, and he is resigning from the board to accept this new position.
Prior to joining the HGS board, Southwell was EVP and CFO at Sepracor, a research-based pharmaceutical company. During his fourteen-year tenure at Sepracor, Southwell advanced through a series of senior management positions with increasing responsibility in finance, corporate planning, development and licensing.
Prior to Sepracor, he was vice president, investment banking division, at Lehman Brothers in New York.
Southwell graduated from Rice University, and received his MBA from the Tuck School of Business at Dartmouth College. He serves as chairman of the board of directors for BioSphere Medical, and is a member of the board of directors of PTC Therapeutics. He also serves as chairman of the Tuck School of Business MBA Advisory Board.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more